Chandra Bhagat Pharma H1 FY27 Net Profit Surges Over Tenfold to ₹264.11 Lakh
Chandra Bhagat Pharma Ltd · Outcome · 13 Nov 2026, 11:40 pm
Chandra Bhagat Pharma H1 FY27 Net Profit Surges Over Tenfold to ₹264.11 Lakh Chandra Bhagat Pharma reported total income of ₹8,297.83 lakh for the half-year ended 30th Sep'26, up 220.5% YoY from ₹2,588.65 lakh in the prior-year period. Revenue from operations jumped 213.7% YoY to ₹8,012.92 lakh. Net profit surged over tenfold YoY to ₹264.11 lakh from ₹22.87 lakh, driving EPS to ₹3.50 from ₹0.30. Operating cash flow stood at negative ₹196.62 lakh, impacted by trade payable reductions. Cash and cash equivalents closed at ₹23.99 lakh as total equity grew to ₹3,576.75 lakh.
Original exchange filing (PDF)
More announcements from Chandra Bhagat Pharma Ltd
- Outcome of the Board Meeting held on 13th November, 2026. · 13 Nov 2026
- Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Result for .... · 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Ramkant Dave · 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chintan Vijay Makhecha · 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Chandravadan Bhagat & PACs · 26 Oct 2026
- Please find attached disclosure under Reg 30 of SEBI (LODR) Regulations, 2015 for your reference. · 22 Oct 2026
- Certificate for Non_Applicability of Corporate Governance Certificate for the quarter ended 30th September, 2026. · 21 Oct 2026
- The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis. · 13 Oct 2026
